Human pharmacokinetics prediction with an in vitro-in vivo correction factor approach and in vitro drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy((R)) for the treatment of HIV-1 infection
- 浏览1
Xenobiotica
1020-1030页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



